H2020Докторантска мрежа2018–2023

QuanTII · Quantitative T cell Immunology and Immunotherapy

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2018-09-01 → 2023-08-31
Финансиране от ЕС
3 923 653 €
Участници
11
Схема
MSCA-ITN

Линиите свързват координатора с партньорите.

Накратко на български

Т-клетките и техните рецептори се анализират чрез нови количествени методи, например при проучване на раковите заболявания. Това помага за по-доброто разбиране на имунната памет и механизмите, чрез които работят имунотерапиите срещу рака.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Quantitative T cell Immunology and Immunotherapy

Health and disease are regulated, to a large extent, by our immune system. The immune system not only protects the body from infectious disease, but is involved in a number of conditions of increasing incidence and morbidity. In cancer, the immune system can be both cause and cure; it contributes to chronic inflammation that promotes tumour development, but it can also provide the ultimate weapon against metastatic disease. Thus, the development of ways to harness, direct or restrain immune responses has great potential for enhancing human health. QuanTII will address the need for new quantitative approaches to query immune cell function in lymphoid organs and tissues by developing novel quantitative methods of (1) the compartmentalisation and dynamics of T cells, (2) T cell receptor (TCR) repertoires in health and disease, in blood and tissues, and (3) T cell immunotherapies. Results from this project will improve our understanding of immunological memory, the variety of immune responses evoked by a single pathogen (immune repertoire), and the molecular and cellular mechanisms at the heart of cancer immunotherapies, such as adoptive cell transfer. The specific training objectives of QuanTII are to provide an inspiring and supportive environment for the training of 15 ESRs, and to establish a broad programme of challenging research projects that are multidisciplinary and intersectoral, and lead to lasting, fruitful collaboration between ETN partners. ESRs carried out research projects in immunological memory, immune repertoires, cancer and immunotherapies. Experimental approaches included sequencing and labelling of thymocytes and stem-cell memory T cells. Theoretical approaches included deterministic models of signalling, of T-cell subsets in exhaustion, and of the effect of checkpoint inhibitors. ESRs developed stochastic models of cell division and death, of the correlation structure of cell fates, and of the maintenance of product cell populations from progenitor cells, probabilistic repertoire models and agent-based models of heterogeneous populations. Modern algebraic and statistical techniques including Bayesian analysis were a feature. Once travel restrictions were relaxed, ESRs were able to undertake secondments and attend network meetings again. We are grateful that all QuanTII academic and industrial partners remained with the network from start to finish, participating in supervision of training and research, organising network events and hosting secondments.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Health and disease are regulated, to a large extent, by our immune system. The immune system not only protects the body from infectious disease, but is involved in a number of conditions of increasing incidence and morbidity, such as diabetes, rheumatoid arthritis, inflammatory bowel disease and allergies. In cancer, the immune system can be both cause and cure; it contributes to chronic inflammation that promotes tumour development, but it can also provide the ultimate weapon against metastatic disease. Thus, the development of ways to harness, direct or restrain immune responses has great potential for enhancing human health. Understanding the mechanisms that control the abundance of different lymphocyte (a type of white blood cell) subsets is key to therapeutically targeting immune responses. Ultimately, this understanding must be sought in quantitative terms, explaining how the rates of cell proliferation, differentiation, survival and death are determined by molecular mechanisms and cellular interactions. Current immunological research is beginning to combine experimental approaches with mathematical analysis to quantitate immune dynamics. A severe obstacle to more rapid progress in this area is the lack of appropriately trained scientists. In this ETN, European scientists, with a rich track record in collaborative research and training, have come together to deliver a highly collaborative, multidisciplinary and intersectoral research training programme for 15 early stage researchers (ESRs) in Quantitative T cell Immunology and Immunotherapy (QuanTII).

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз